Abbott Laboratories: 10-K Risk Factor Changes

2026 vs 2025  ·  SEC EDGAR  ·  2026-10-16
⚠ AI Risk Brief Interpretation layer — deterministic data below

Abbott added geopolitical risk disclosure while removing infectious disease and international business risks, reflecting shifted strategic concerns.

✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

1
New Risks
2
Removed
4
Modified
15
Unchanged
🟢 New in Current Filing Disclosure change10/10

Changes in geopolitical and macroeconomic conditions could negatively affect Abbott’s business, financial condition, and results of operations.

🔴 No Match in Current Filing The international nature of Abbott’s business subjects it to additional business risks that may cause its revenue and profitability to decline. 🔒
🔴 No Match in Current Filing Abbott is subject to risks related to public health crises, such as widespread outbreaks of infectious diseases, which could have a material effect on Abbott’s business, financial condition and results of operations. 🔒
🟡 Modified Other factors can have a material adverse effect on Abbott’s future profitability and financial condition. 🔒

And 3 more changes in the full comparison.

6 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get Pro access Already a Pro subscriber? View full diff →